eGCX also prevents microvascular thrombosis and limits leukocyte adhesion through interactions with plasma albumin, antithrombin-III (AT-III), and extracellular superoxide dismutase-3 (SOD3), among other proteins [12]. The gene discussed is SERPINC1; the disease is deep vein thrombosis.